Sphera Funds Management’s Dova Pharmaceuticals DOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DOVA
Sphera Funds Management's DOVA Position: Q1 2019 in Review
Sphera Funds Management sold out of Dova Pharmaceuticals (DOVA) in Q1 2019, closing a stake of 185,000 shares — an estimated $1.4M sold.
Sphera Funds Management first reported a position in DOVA in Q2 2017 and held it in 4 quarters. The position peaked at $2.52M in Q3 2018. 59 funds tracked by Wall St. Rank hold DOVA as of Q1 2019.
- Sphera Funds Management reported no remaining Dova Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
- Sphera Funds Management sold 185,000 Dova Pharmaceuticals shares in Q1 2019, an estimated $1.4M.
- Sphera Funds Management first reported a position in Dova Pharmaceuticals in Q2 2017 and held it in 4 quarters.
- Sphera Funds Management's Dova Pharmaceuticals position peaked at $2.52M in Q3 2018.
- 59 funds tracked by Wall St. Rank held Dova Pharmaceuticals as of Q1 2019.
Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.